MLKL and CaMKII Are Involved in RIPK3-Mediated Smooth Muscle Cell Necroptosis

Ting Zhou1, Elise DeRoo1, Huan Yang1

  • 1Department of Surgery, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.

Cells
|September 28, 2021
PubMed

Insights

Receptor interacting protein kinase 3 (RIPK3) triggers smooth muscle cell (SMC) necroptosis in abdominal aortic aneurysms (AAAs). This study reveals mixed lineage kinase domain-like pseudokinase (MLKL) acts upstream of calcium/calmodulin-dependent protein kinase II (CaMKII) in this RIPK3-mediated process.

Area of Science:

  • Cardiovascular Biology
  • Cell Death Pathways
  • Molecular Signaling

Background:

  • Receptor interacting protein kinase 3 (RIPK3)-mediated necroptosis in smooth muscle cells (SMCs) contributes to abdominal aortic aneurysm (AAA) pathogenesis.
  • The precise downstream signaling cascade of RIPK3 in SMC necroptosis remains largely unelucidated.

Purpose of the Study:

  • To investigate the roles of mixed lineage kinase domain-like pseudokinase (MLKL) and calcium/calmodulin-dependent protein kinase II (CaMKII) in RIPK3-dependent SMC necroptosis.
  • To determine the sequential order of MLKL and CaMKII activation in this pathway.

Main Methods:

  • Utilized a murine CaCl2-induced abdominal aortic aneurysm model.
  • Employed in vitro TNFα plus zVAD-FMK stimulation of mouse aortic SMCs to induce necroptosis.
  • Investigated the effects of MLKL and CaMKII inhibition/silencing on cell death and signaling events using siRNA and specific inhibitors.

Main Results:

  • Both MLKL and CaMKII were phosphorylated in SMCs during AAA development and in vitro necroptosis induction.
  • RIPK3 deficiency attenuated MLKL and CaMKII phosphorylation.
  • MLKL knockdown reduced SMC necroptosis and CaMKII phosphorylation, while CaMKII inhibition/silencing partially inhibited necroptosis without affecting MLKL.
  • MLKL activation appears to precede CaMKII activation in the RIPK3-mediated necroptosis pathway.

Conclusions:

  • MLKL and CaMKII are both critical effectors in RIPK3-mediated SMC necroptosis.
  • MLKL functions upstream of CaMKII in the signaling pathway leading to SMC death in AAA pathogenesis.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
5.0K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.2K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.7K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.8K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.0K